Delayed Nyse  -  05/20 04:00:02 pm EDT
27.18 USD   +0.04%
05/04Turning Point Brands Declares Common Stock Dividend
05/04Turning Point Brands Declares Common Stock Dividend, Payable on July 8, 2022
05/02TURNING POINT BRANDS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

TopNewsGuide: CORRECTION: Real Brands, Inc.'s (OTCMKTS: RLBD) Affiliation With Turning Points Brands (NYSE: TPB) And Standard General Attracts Investors

12/20/2021 | 09:01am EDT

(CORRECTION - The correct symbol for Turning Point Brands mentioned in this article is (NYSE:TPB))

Real Brands, Inc. (OTCMKTS: RLBD) is attracting attention from investors. RLBD is in the fast-growing marijuana/hemp space with proprietary brands.

But the real interest in RLBD stock is the Company's affiliation with Turning Points Brands, Inc. (NYSE: TPB) and $9 billion assets under management (AUM) hedge fund Standard General.

This is not a typical pink sheet penny stock. TPB owns 23% equity interest in RLBD stock. In turn, private hedge fund Standard General owns less than 20% equity ownership of TPB.

All are in the marijuana/hemp adult consumer alternative smoking space.

Connecting The Equity Ownership Dots

Not only is RLBD stock cross-owned by these financial giants, executive talent connects the dots on these three companies. Investors are interested.

David Glazek is chairman of TPB and is also a founding Partner at Standard General

Jim Dobbins is TPB's nominee on RLBD's Board. He is retired as long time in-house general counsel at TPB. He is further retained by a two-year consulting agreement.

Thom Kidrin, president and CEO of RLBD, says another Board member of RLBD, Jeffrey Engel, was instrumental in obtaining TPB's involvement. Engel, an investment consultant with 33 years experience on Wall Street, helped attract TPB to RLBD.

The common interest between RLBD, strategic investor TPB and hedge fund SG is the marijuana/cannabis space. All are in branded products in alternative adult consumer smoking.

Last week, TBD named Board member Yavor Efremov president and CEO. It owns ZigZag® and Stoker's® brands in the alternative spoking space. TPB reported sales increased by 11.9% to $405.1million in 2020. SG hedge fund reported $969.8 million total assets (AUM). It operates some 20 private funds.

Engineering A Reverse Merger

Kidrin launched RLBD when he engineered a reverse merger with Canadian American Standard Hemp (CASH) a pink sheet company. He left MariMed, Inc. (OTCQX): MRMD) to launch RLBD.

Kidrin credits board member Jeffrey Engel with attracting TPB as a strategic investor in RLBD. Now, TPB's Dobbins sits on RLBD's Board. Glazek completes the three-way equity ownership circle as Chairman of TPB while serving as SG founding Partner.

All that cross equity ownership is unique in the penny stock world. This is billion dollar corporations owning pink sheet RLBD stock.

Kidrin in an exclusive interview says he anticipates a revised up list filing from RLBD to the OTCQB exchange by year's end. RLBD has already filed a Form 10 and is a fully reporting company.

"We will meet the 10% stock eligibility regulation and plan to file a revised legal opinion letter within a few weeks, by year's end," Kidrin says."It will amend subsequent events."

RLBD's Expansion Plans For 2022

After the applied-for up list in the new year is approved, Kidrin has major plans for RLBD

"I have five major deals waiting for us after the up list," Kidrin says. "Once that is finalized, everything else can start. I can announce them.":

Kidrin says RLBD is already consulting with a major CBD beverage seltzer brand on new product. In 2022, RLBD may be looking at an M&A transaction. With TPB and SG affiliations, Kidrin seemingly can achieve it.

He plans to expand the newly-launched PHAZE sports wellness line targeted to athletes. He will grow it from eight SKUs to 20 products in 2022, he says. Now it is sold exclusively in its own online store.

Next year, Kidrin plans to announce an international distribution arrangement. In 2022, RLBD plans to expand PHAZE further from its current eight SKUs to some 20 products. Gummies will be added to the PHAZE line

Kidrin said he is also discussing PHAZE brick-and-mortar sales with a major domestic distributor. That would mean sales at bodegas, convenience stores, gas stations and other frequently-visited locations.

To raise the profile of planned CBD creams in cosmetics, he is actively talking with celebrity actress Sharon Stone. She would serve as an 'influencer' promoting the line on social media.

He says he is planning a new golf-driven sports CBD line. Kidrin says he is in talks with major athletic groups.

Learn more at https://realbrands.com/

Twitter https://twitter.com/RealBrandsInc

LinkedIn https://www.linkedin.com/company/real-brands-inc

Keep Real Brands, Inc. on your Watch List as hemp-infused products and CBD are growing in importance to the investor community.

Read our coverage of RLBD here: https://topnewsguide.com/?s=rlbd&x=11&y=6

Disclaimers: TopNewsGuide 'TNG' is responsible for the production and distribution of this content. TNG is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by TNG is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall TNG. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by TNG., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. TNG. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, TNG., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. TNG has been compensated up to five-thousand dollars cash via wire transfer by a third party to produce and syndicate content for RLBD Real Brands. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

CONTACT: Mark McKelvie


(754) 233-0966


(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

Stocks mentioned in the article
ChangeLast1st jan.
REAL BRANDS, INC. 2.80% 0.0257 Delayed Quote.-28.61%
TURNING POINT BRANDS, INC. 0.04% 27.18 Delayed Quote.-28.06%
05/04Turning Point Brands Declares Common Stock Dividend
05/04Turning Point Brands Declares Common Stock Dividend, Payable on July 8, 2022
05/02TURNING POINT BRANDS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K..
04/27TURNING POINT BRANDS, INC. Management's Discussion and Analysis of Financial Condition..
04/27Tranche Update on Turning Point Brands, Inc.'s Equity Buyback Plan announced on Februar..
04/27TRANSCRIPT : Turning Point Brands, Inc. - Shareholder/Analyst Call
04/27TURNING POINT BRANDS : Announces First Quarter 2022 Results - Form 8-K
04/27TURNING POINT BRANDS, INC. : Results of Operations and Financial Condition, Regulation FD ..
04/27Turning Point Brands, Inc. Reports Earnings Results for the First Quarter Ended March 3..
04/27Turning Point Brands Posts Decline in Q1 Adjusted Earnings, Net Sales
More news
Analyst Recommendations on TURNING POINT BRANDS, INC.
More recommendations
Financials (USD)
Sales 2022 434 M - -
Net income 2022 55,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 11,3x
Yield 2022 0,85%
Capitalization 493 M 493 M -
Capi. / Sales 2022 1,14x
Capi. / Sales 2023 1,07x
Nbr of Employees 426
Free-Float 88,1%
Duration : Period :
Turning Point Brands, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TURNING POINT BRANDS, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 4
Last Close Price 27,18 $
Average target price 49,50 $
Spread / Average Target 82,1%
EPS Revisions
Managers and Directors
Yavor Efremov President, Chief Executive Officer & Director
Louie Reformina Chief Financial Officer & Senior Vice President
David E. Glazek Chairman
Christian Allen Senior Vice President-Information Technology
Sarah Evans Director-Scientific & Regulatory Affairs